xCures logo — Right Patient, Right Treatment, Right Time.

xCures

Right Patient, Right Treatment, Right Time.

Founded 2018 United States Oakland, United States 42 employees Convertible Note Total: $12.97M AI, Biotechnology +3

General Information

Company Name xCures
Founded Year 2018
Location United States Oakland, United States
Employees 42
Industries AI, Biotechnology, Health Care +2
Funding Stage Convertible Note
Social

BounceWatch is an independent company data service, not affiliated with xCures. To contact xCures, visit xcures.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does xCures compare?

A PDF of xCures and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting xCures soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About xCures

xCures is a biotechnology and healthcare startup, established in 2018, with a slogan of "Right Patient, Right Treatment, Right Time." The company focuses on healthcare data management, aiming to achieve data completeness and provide real-time data access. xCures gathers and standardizes detailed medical records from various healthcare sources, including direct retrieval from US institutions, patient portals, and electronic health exchanges. Utilizing Natural Language Processing, the collected data is digitized, organized, and examined to identify features, resulting in a comprehensive longitudinal patient journey that covers everything from genomics to social determinants of health. The company has processed over 140 million records from thousands of different medical practices and implemented its technology for a significant number of patients. All collected data elements are thoroughly annotated in a central Electronic Data Capture (EDC) system to ensure standardization and ongoing accuracy. The company offers clinically actionable, real-time insights through a range of tools and products to support the care of patients, providers, and partners. The latest investment in xCures was a Convertible Note investment at 01 December 2023, and the investor was HealthTech Capital. For further information, interested parties can contact [email protected] or visit http://www.xcures.com.

Business keywords: Healthcare Data Management, Real World Evidence, Precision Medicine, Health Technology, Clinical Software, Observational Studies, Decentralized Trials, Genomics, Oncology, Medical Records, Electronic Data Capture, Patient Engagement, Natural Language Processing

Funding Rounds & Investors (9)

View All
Funding Stage Amount Investors Lead Investors Date
Convertible Note Undisclosed 1
HealthTech Capital
01 Dec 2023
Series A Undisclosed 2
Portfolia, CommerceNet
11 Apr 2022
Series A $125.00K 1
Portfolia
06 Nov 2021
Series A $12.69M 5
Harmonix Fund, HealthTech Capital +3
23 Jun 2021
Convertible Note $150.00K -
21 Apr 2021
Series A Undisclosed 1
Harmonix Fund
15 Sep 2020
Venture Round Undisclosed 1
Vanedge Capital
01 Jan 2020
Seed Round Undisclosed 1
Wavemaker 360
06 Jun 2019
Seed Round Undisclosed 1
Lauder Partners
01 Feb 2018

xCures Alternatives & Competitors

View All Alternatives
xCures vs
Embleema
Embleema United States

Regulatory-grade real-world data platform for registries, research teams, and patient-driven discove...

Series A
30 employees
Biotechnology, Health Care
xCures vs

The complete Genomic Health Record unifying genomic workflows with a single, EHR-integrated software...

Seed
24 employees
Biotechnology, Health Care
xCures vs
Sano Genetics
Sano Genetics United Kingdom

Accelerating the world's transition to precision medicine.

50 employees
Biopharma, Biotechnology

FAQ About xCures

Right Patient, Right Treatment, Right Time.
xCures was founded in 2018.
xCures is headquartered in Oakland, United States.
xCures operates in AI, Biotechnology, Health Care, Pharmaceutical and Machine Learning. Its work centres on Healthcare Data Management, Real World Evidence, Precision Medicine and Health Technology.
xCures has approximately 42 employees.
xCures has completed 9 funding rounds, raising a total of $12.97M. The latest funding stage is Convertible Note.
Top alternatives and competitors to xCures include Embleema, PhenoTips, Sano Genetics, Savana, Castor. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
xCures and Embleema are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for xCures, https://bouncewatch.com/company/xcures, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes